ANDA 86766, held by Wendt. Nitrofurazone.
As of Nov 14, 2026, ANDA 86766 (Nitrofurazone), held by Wendt, was first approved by FDA on May 11, 1981, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 11, 1981 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Nitrofurazone0.2% ยท ointment;topical | Nitrofurazone | Discontinued |
| Feb 17, 1982 | Supplement 1Manufacturing | Approved | None posted |
| Feb 17, 1982 | Supplement 3Manufacturing | Approved | None posted |
| May 11, 1981 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
